Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality in motion Quality Strong, Valuation Fairly Valued, Momentum Bullish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).
Ranks #83 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 29 Sep 2026 | QE SECURITIES LLP | Bulk | Sell | 147,373 | 547.1100 | NSE |
| 29 Sep 2026 | QE SECURITIES LLP | Bulk | Buy | 143,855 | 551.6900 | NSE |
| 29 Sep 2026 | ALPHAGREP SECURITIES PRIVATE LIMITED | Bulk | Sell | 166,836 | 547.9700 | NSE |
| 29 Sep 2026 | ALPHAGREP SECURITIES PRIVATE LIMITED | Bulk | Buy | 166,836 | 547.6100 | NSE |
| 29 Sep 2026 | ALPHAGREP SECURITIES PRIVATE LIMITED | Bulk | Sell | 166,836 | 547.9700 | NSE |
| 29 Sep 2026 | QE SECURITIES LLP | Bulk | Sell | 147,373 | 547.1100 | NSE |
| 29 Sep 2026 | QE SECURITIES LLP | Bulk | Buy | 143,855 | 551.6900 | NSE |
| 29 Sep 2026 | ALPHAGREP SECURITIES PRIVATE LIMITED | Bulk | Buy | 166,836 | 547.6100 | NSE |
| 28 Sep 2026 | THAKKAR PREETI | Bulk | Sell | 1,165,938 | 474.6500 | NSE |
| 28 Sep 2026 | MOLECULE VENTURES LIMITED LIABILITY PARTNERSHIP | Bulk | Buy | 257,000 | 475.2500 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 5 Aug 2026 | Dividend - Rs 3.75 Per Share | 3.7500 | 5 Aug 2026 |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| — | NAME_CHANGE | Name changed from Dil Limited. to FERMENTA BIOTECH LIMITED |
| — | NAME_CHANGE | Name changed from Duphar-Interfran Ltd. to Dil Limited. |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 11 Aug 2026 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 1 Oct 2026 | Company Update | Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 1 Oct 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Fermenta Biotech Limited has informed the Exchange about Schedule of investor(s) meeting to be held on October 07, 2026. |
| 30 Sep 2026 | Insider Trading / SAST | Fermenta Biotech Ltd - 506414 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 |
| 29 Sep 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Fermenta Biotech Limited has informed the Exchange about Schedule of investor(s) meeting to be held on October 05, 2026. |
| 29 Sep 2026 | Trading Window | Fermenta Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 29 Sep 2026 | Insider Trading / SAST | Fermenta Biotech Ltd - 506414 - Closure of Trading Window |
| 29 Sep 2026 | Company Update | Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 24 Sep 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Fermenta Biotech Limited has informed the Exchange about Schedule of investor(s) meet |
| 21 Sep 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Fermenta Biotech Limited has informed the Exchange about Schedule of investor(s) meeting. |
| 21 Sep 2026 | Company Update | Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
